Navigation Links
Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
Date:9/26/2011

in this patient population, in addition to providing superior functional and cosmetic outcomes for those patients with recurrent or otherwise complicated and difficult to treat skin cancers.  This simple and novel delivery of bleomycin, an approved chemotherapeutic agent, through reversible electroporation has shown a marked improvement in potency, while delivering a much lower and safer concentration of the drug."

"With positive results from these multiple clinical studies, OMS ElectroChemotherapy™ demonstrates clinical benefit for patients with manageable side effects," said, Punit Dhillon, president and CEO. "We strongly believe in the clinical relevance of our therapeutic approach and believe these results demonstrate tolerability, efficacy and point to the combinability of this novel treatment approach with current available therapies for the management of local tumors.  Clinical experience from these programs supports the uniqueness of OMS ElectroChemotherapy™ in its ability to achieve selective destruction of cancerous tumors while sparing healthy normal tissue including highly vascularized and innervated surrounding structures, providing physicians with an important flexible treatment alternative."

About OncoSec Medical Inc.

OncoSec Medical (OTCBB: ONCS) develops novel OMS ElectroOncology therapies that combine its proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics. Targeted local delivery of these agents is designed to achieve selective destruction of cancerous tumors while sparing healthy normal tissue, resulting in improved functional, cosmetic and quality of life outcomes. These therapies have achieved validating safety and efficacy data in early and late stage clinical studies of over 400 cancer patients. OncoSec's clinical programs include three Phase II clinical trials for OMS ElectroImmunotherapy™. More information is available at '/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. UPDATE: Total Victory for Schering-Plough (Now Merck) Pharmaceutical Reps in National Suit for Overtime Pay
2. UPDATE: FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
3. Update: Clinical Trial Establishes Catheter-based Aortic Valve Replacement As New Standard of Care for Patients Who Cannot Undergo Surgery
4. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
5. Update: International HIV/AIDS Partnership Wins Two Awards for Supply Chain Excellence
6. UPDATE: FDA Issues 22 Warning Letters to Web site Operators
7. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
8. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
9. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015 RnRMarketResearch.com adds ... research report that provides an overview of syringes ... sourced from in-house databases, secondary and primary research. ... market products pipeline spread across 124 pages, talking ... tables and 5 figures is now available at ...
(Date:7/31/2015)... , July 31, 2015 Quietly, ... of experience, the domestic pharmaceutical industry is strong, with ... products to high international standards. One place ... is in sub-Saharan Africa: Morocco has quietly become the ... South Africa . Indeed, Moroccan pharma companies ...
(Date:7/31/2015)... -- According to a new market research ... (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement ... Forecast to 2019", published by MarketsandMarkets, the global Body ... and is estimated to grow to $1,425.7 Million by ... to 2019. Browse 41 market data ...
Breaking Medicine Technology:Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... in Small, Ambulatory Physician PracticesSCHAUMBURG, Ill., March 3 ... Information Technology (CCHIT(R)), the federally recognized body for ... announced it will develop dermatology-specific functionality criteria beginning ... a response to an application from the American ...
... OF 10.5 MONTHS IN COMPLETE RESPONDERS- FINAL DATA ... Calif., March 3 Hana Biosciences (Nasdaq: ... efficacy results from a planned interim analysis of ... (vincristine sulfate liposomes injection) for the treatment of ...
Cached Medicine Technology:Certification Commission for Healthcare Information Technology to Develop Dermatology-Specific Functionality Criteria for Electronic Health Record (EHR) Technology 2Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 2Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 3Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 4Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 5
(Date:7/31/2015)... Santa Clara, CA (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 ... The National Football League’s biggest day each year is the Super Bowl. In the ... buildup that takes place from the host venue. The 2016 Super Bowl game will mark ...
(Date:7/31/2015)... VA (PRWEB) , ... July 31, 2015 , ... ... introduced its new store run by GoodThreads. The store can be accessed by ... and designs, many of which are customizable. The best part: whenever a product ...
(Date:7/31/2015)... ... July 31, 2015 , ... Jacksonville-based ... its new True North Conference Center. The medical community, social workers, law enforcement, ... may be more aligned in the effort to better understand and combat sex ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source of authentic ... a new and refreshing show on Broadway, look no further than Hamilton. This American ... Award, Outer Critics Circle Award, Drama Desk Award, Lucille Lortel Award, and New York ...
(Date:7/31/2015)... (PRWEB) , ... July 31, ... ... Jason T. Brown’s live lecture on pharmaceutical negligence is now available online ... was well received with a 94% approval rating from the nationwide audience. ...
Breaking Medicine News(10 mins):Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2
... NORTH HOLLYWOOD, Calif., June 17 IPC The,Hospitalist Company, ... group practice, today announced that it continues to experience,favorable ... net,revenues to be in the range of $57 million ... range of $4.2 million to $4.6 million. Absent the,impact ...
... CEO Scott Kornhauser,announced the appointment of Bryan Hebert ... Hebert was a former consulting partner with,over 18 ... in the healthcare,industry., Mr. Hebert,s responsibilities will ... market share for Healthation. Prior to,joining Healthation, Mr. ...
... Men whose tumors recur after prostate cancer surgery are ... term if they undergo radiotherapy within two years of ... whose new tumors were growing fastest, according to results ... Hopkins Medical Institutions researchers reported June 18 in the ...
... in DNA, study finds, , , TUESDAY, June 17 (HealthDay ... when it comes to cancer risk, according to a ... research suggests that stringent dietary changes, getting more exercise ... hundreds of genes. Some of the changes positively ...
... HILL, N.C., June 17 Across industry sectors,sales ... common operational, strategic and time management practices,according to ... LLC., The study shows the client still ... spend 21 percent of their time,building solutions for ...
... the death rate and might need to be used ... News) -- Countering common medical theory, a new study ... many men whose prostate cancer recurs aggressively after surgery. ... that recurs after surgery seem to benefit from salvage ...
Cached Medicine News:Health News:IPC The Hospitalist Company, Inc. Provides Second Quarter 2008 Outlook 2Health News:IPC The Hospitalist Company, Inc. Provides Second Quarter 2008 Outlook 3Health News:IPC The Hospitalist Company, Inc. Provides Second Quarter 2008 Outlook 4Health News:Radiation therapy prolongs life in men with recurrent prostate cancer 2Health News:Lifestyle Changes Affect Cancer Genes 2Health News:Lifestyle Changes Affect Cancer Genes 3Health News:High-Performing Sales Forces Share Key Practices to Achieve Optimal Performance 2Health News:Radiation May Help When Prostate Cancer Returns 2Health News:Radiation May Help When Prostate Cancer Returns 3
PLX40s, 40 Watt Sealed CO2 Laser System....
... connects via a USB port ... computer featuring Windows 2000 or ... the art corneal topography software ... projection and easy alignment reduce ...
... Atlas Eclipse model 995 is ... It offers ultra-low illumination and ... model 995 is ideal for ... lens specialists who require comprehensive ...
... only corneal topographer available with a ... Pupillometer.,The German-engineered Keratograph delivers real "K" ... for refractive surgery or contact lens ... infrared Pupillometer allows the measurement of ...
Medicine Products: